Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Cash from Financing Activities (2022 - 2025)

Historic Cash from Financing Activities for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$2000.0.

  • PAVmed's Cash from Financing Activities changed N/A to -$2000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year change of. This contributed to the annual value of $31.3 million for FY2024, which is 35.61% up from last year.
  • Per PAVmed's latest filing, its Cash from Financing Activities stood at -$2000.0 for Q3 2025.
  • PAVmed's 5-year Cash from Financing Activities high stood at $25.5 million for Q2 2022, and its period low was -$2000.0 during Q3 2025.
  • Its 4-year average for Cash from Financing Activities is $7.6 million, with a median of $2.8 million in 2025.
  • The largest annual percentage gain for PAVmed's Cash from Financing Activities in the last 5 years was 778734.18% (2023), contrasted with its biggest fall of 9761.42% (2023).
  • PAVmed's Cash from Financing Activities (Quarter) stood at $80000.0 in 2022, then surged by 6510.0% to $5.3 million in 2023, then crashed by 93.76% to $330000.0 in 2024, then tumbled by 100.61% to -$2000.0 in 2025.
  • Its Cash from Financing Activities was -$2000.0 in Q3 2025, compared to $2.5 million in Q2 2025 and $3.1 million in Q1 2025.